Trial Profile

Clinical trial of parathyroid hormone and alendronate [alendronic acid] in combination in the treatment of osteoporosis

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 24 Oct 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

02 Sep 2025 According to an Ascendis Pharma media release, the company announced that result data from the study will be presented at ASBMR 2025, the annual meeting of the American Society for Bone & Mineral Research being held in Seattle from September 5-8, 2025.
21 Oct 2020 According to an Ascendis Pharma media release, data from this trial will be presented at European Calcified Tissue Society (ECTS) 2020.
10 Sep 2020 According to an Ascendis Pharma media release Dr. Khan is the primary investigator .

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com